Skip to Main Content

Paper Details

A population-based meta-analysis of circulating GFAP for cognition and dementia risk.
Ann Clin Transl Neurol
7
2022
Alzheimer's disease, Alzheimer's disease dementia, GFAP, apolipoprotein E, circulating, cognitive decline, dementia, diabetes, glial fibrillary acidic protein, reactive astrocytosis
Author NameAffiliation
Joshua C BisCardiovascular Health Research Unit, University of Washington
Kenneth J MukamalBeth Israel Deaconess Medical Center
Bruce M PsatyCardiovascular Health Research Unit, University of Washington
Bruce M PsatyUniversity of Washington
Bruce M PsatyUniversity of Washington
Bruce M PsatyUniversity of Washington
Thomas H MosleyUniversity of Mississippi Medical Center
Vilmundur GudnasonIcelandic Heart Association Research Institute
Vilmundur GudnasonUniversity of Iceland
Oscar L LopezUniversity of Pennsylvania
Kristine YaffeUniversity of California san francisco
Kristine YaffeUniversity of California san francisco
Kristine YaffeUniversity of California san francisco
Kristine YaffeSan Francisco VA Medical Center
Robert Nick BryanUniversity of Pennsylvania
Ilya M NasrallahUniversity of Pennsylvania
Charles DeCarliUniversity of California davis
Lenore J LaunerNational Institute on Aging
Myriam FornageBrown Foundation of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston
Russell P TracyLarner College of Medicine, University of Vermont
  • 1 - 20

Datasets

Release 1.2